25866 Federal Register / Vol. 79, No. 87 / Tuesday, May 6, 2014 / Notices 

Oostdyk, both of Plymouth, Minnesota; 

Justin Gabrielse, Maple Grove, 

Minnesota; Jayne Locascio, Palos Park, 

Illinois; William Oostdyk, South Elgin, 

Illinois; Valerie Therrien, Minneapolis, 

Minnesota; Katie Nelson, Frostburg, 

Maryland; and Keith Gabrielse, Cottage 

Grove, Wisconsin; together as a group 

acting in concert, to retain voting shares 

of Oak Financial, Inc., and thereby 

indirectly retain voting shares of Oak 

Bank, both in Fitchburg, Wisconsin. 

B. Federal Reserve Bank of Kansas 

City (Dennis Denney, Assistant Vice 

President) 1 Memorial Drive, Kansas 

City, Missouri 64198–0001: 

1. Tommy D. Craighead, Norman, 

Oklahoma, as trustee of the TCC & BJC 

Trusts No. 1 through 7, Ardmore, 

Oklahoma; to acquire voting shares of 

Citizens Commerce Corporation, and 

thereby indirectly acquire voting shares 

of Citizens Bank & Trust Company of 

Ardmore, both in Ardmore, Oklahoma. 

Board of Governors of the Federal Reserve 

System, May 1, 2014. 

Michael J. Lewandowski, 

Associate Secretary of the Board. 

[FR Doc. 2014–10323 Filed 5–5–14; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meeting 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice. 

SUMMARY: In accordance with section 10 

(a) (2) of the Federal Advisory 

Committee Act (5 U.S.C. App. 2), 

announcement is made of an Agency for 

Healthcare Research and Quality 

(AHRQ) Special Emphasis Panel (SEP) 

meeting on ‘‘AHRQ RFA–HS14–005, 

Patient Safety Learning Laboratories; 

Applying Design Innovation and 

Systems Engineering (P30)’’. Each SEP 

meeting will commence in open session 

before closing to the public for the 

duration of the meeting. 

DATES: May 29, 2014 (Open on May 29 

from 8:00 a.m. to 8:30 a.m. and closed 

for the remainder of the meeting). 

ADDRESSES: Gaithersburg Marriott 

Washingtonian Center, 9751 

Washingtonian Boulevard, Gaithersburg, 

Maryland 20878. 

FOR FURTHER INFORMATION CONTACT: 

Anyone wishing to obtain a roster of 

members, agenda or minutes of the nonconfidential portions of this meeting 

should contact: Mrs. Bonnie Campbell, 

Committee Management Officer, Office 

of Extramural Research, Education and 

Priority Populations, AHRQ, 540 

Gaither Road, Room 2038, Rockville, 

Maryland 20850, Telephone: (301) 427– 

1554. 

Agenda items for this meeting are 

subject to change as priorities dictate. 

SUPPLEMENTARY INFORMATION: A Special 

Emphasis Panel is a group of experts in 

fields related to health care research 

who are invited by the Agency for 

Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Each SEP meeting will commence in 

open session before closing to the public 

for the duration of the meeting. The SEP 

meeting referenced above will be closed 

to the public in accordance with the 

provisions set forth in 5 U.S.C. App. 2, 

section 10(d), 5 U.S.C. 552b(c)(4), and 5 

U.S.C. 552b(c)(6). Grant applications for 

the ‘‘AHRQ RFA–HS14–005, Patient 

Safety Learning Laboratories: Applying 

Design Innovation and Systems 

Engineering (P30)’’ are to be reviewed 

and discussed at this meeting. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Dated: April 25, 2014. 

Richard Kronick, 

AHRQ Director. 

[FR Doc. 2014–10277 Filed 5–5–14; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Patient Safety Organizations: 

Voluntary Relinquishment From 

Medical Peer Review Resource, LLC 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), Department of 

Health and Human Services (HHS). 

ACTION: Notice of Delisting. 

SUMMARY: The Patient Safety and 

Quality Improvement Act of 2005, 42 

U.S.C. 299b–21 to b-26, (Patient Safety 

Act) and the related Patient Safety and 

Quality Improvement Final Rule, 42 

CFR part 3 (Patient Safety Rule), 

published in the Federal Register on 

November 21, 2008, 73 FR 70732– 

70814, provide for the formation of 

Patient Safety Organizations (PSOs), 

which collect, aggregate, and analyze 

confidential information regarding the 

quality and safety of healthcare 

delivery. The Patient Safety Rule 

authorizes AHRQ, on behalf of the 

Secretary of HHS, to list as a PSO an 

entity that attests that it meets the 

statutory and regulatory requirements 

for listing. A PSO can be ‘‘delisted’’ by 

the Secretary if it is found to no longer 

meet the requirements of the Patient 

Safety Act and Patient Safety Rule, 

when a PSO chooses to voluntarily 

relinquish its status as a PSO for any 

reason, or when a PSO’s listing expires. 

AHRQ has accepted a notification of 

voluntary relinquishment from Medical 

Peer Review Resource, LLC of its status 

as a PSO, and has delisted the PSO 

accordingly. Medical Peer Review 

Resource, LLC submitted this request for 

voluntary relinquishment during 

revocation proceedings for cause. 

DATES: The directories for both listed 

and delisted PSOs are ongoing and 

reviewed weekly by AHRQ. The 

delisting was effective at 12:00 Midnight 

ET (2400) on April 2, 2014. 

ADDRESSES: Both directories can be 

accessed electronically at the following 

HHS Web site: http:// 

www.pso.AHRQ.gov/index.html. 

FOR FURTHER INFORMATION CONTACT: 

Eileen Hogan, Center for Quality 

Improvement and Patient Safety, AHRQ, 

540 Gaither Road, Rockville, MD 20850; 

Telephone (toll free): (866) 403–3697; 

Telephone (local): (301) 427–1111; TTY 

(toll free): (866) 438–7231; TTY (local): 

(301) 427–1130; Email: 

pso@AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The Patient Safety Act authorizes the 

listing of PSOs, which are entities or 

component organizations whose 

mission and primary activity are to 

conduct activities to improve patient 

safety and the quality of health care 

delivery. 

HHS issued the Patient Safety Rule to 

implement the Patient Safety Act. 

AHRQ administers the provisions of the 

Patient Safety Act and Patient Safety 

Rule relating to the listing and operation 

of PSOs. The Patient Safety Rule 

authorizes AHRQ to list as a PSO an 


sroberts on DSK5SPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 87 / Tuesday, May 6, 2014 / Notices 25867 

entity that attests that it meets the 

statutory and regulatory requirements 

for listing. A PSO can be ‘‘delisted’’ if 

it is found to no longer meet the 

requirements of the Patient Safety Act 

and Patient Safety Rule, when a PSO 

chooses to voluntarily relinquish its 

status as a PSO for any reason, or when 

a PSO’s listing expires. Section 3.108(d) 

of the Patient Safety Rule requires 

AHRQ to provide public notice when it 

removes an organization from the list of 

federally approved PSOs. 

AHRQ has accepted a notification 

from Medical Peer Review Resource, 

LLC, PSO number P0026, to voluntarily 

relinquish its status as a PSO. 

Accordingly, Medical Peer Review 

Resource, LLC was delisted effective at 

12:00 Midnight ET (2400) on April 2, 

2014. Medical Peer Review Resource, 

LLC, submitted this request for 

voluntary relinquishment during 

revocation proceedings for cause. 

Medical Peer Review Resource, LLC 

has patient safety work product (PSWP) 

in its possession. The PSO will meet the 

requirements of section 3.108(c)(2)(i) of 

the Patient Safety Rule regarding 

notification to providers that have 

reported to the PSO. In addition, 

according to sections 3.108(c)(2)(ii) and 

3.108(b)(3) of the Patient Safety Rule 

regarding disposition of PSWP, the PSO 

has 90 days from the effective date of 

delisting and revocation to complete the 

disposition of PSWP that is currently in 

the PSO’s possession. 

More information on PSOs can be 

obtained through AHRQ’s PSO Web site 

at http://www.pso.AHRQ.gov/ 

index.html. 

Dated: April 25, 2014. 

Richard Kronick, 

AHRQ Director. 

[FR Doc. 2014–10279 Filed 5–5–14; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–76, dated 

October 14, 1980, and corrected at 45 FR 

69296, October 20, 1980, as amended 

most recently at 79 FR 21760–21763, 

dated April 17, 2014) is amended to 

establish the World Trade Center Health 

Program, National Institute for 

Occupational Safety and Health, Centers 

for Disease Control and Prevention. 

Section C–B, Organization and 

Functions, is hereby amended as 

follows: 

After the title and functional 

statement for the Division of 

Compensation Analysis and Support 

(CCN), National Institute for 

Occupational Safety and Health (CC), 

insert the following: 

World Trade Center Health Program 

(CCP). (1) Provides the leadership and 

management to comply with the 

responsibilities under the James 

Zadroga 9/11 Act of 2010; Title) (XXIII 

of the Public Health Service Act; (2) 

administers the World Trade Center 

Health Program (WTCHP); (3) develops, 

implements, and maintains a WTCHP 

quality assurance program; (4) provides 

annual reports to Congress; (5) consults 

with stakeholders in carrying out the 

WTCHP mission; (6) establishes and 

administers a WTCHP Scientific 

Technical Advisory Committee; (7) 

develops and implements an education 

and outreach program; (8) provides for 

uniform data collection and for data 

integration; (9) provides for 

collaboration between Data Centers and 

World Trade Center (WTC) Health 

Registry; (10) enters into and oversees 

contracts for Clinical Centers of 

Excellence, Data Centers, and 

Nationwide Provider Networks; (11) 

enters into agreement with New York 

City for purposes of collecting 10% of 

the specified funds stated in the 

Zadroga 9/11 Act of 2010; (12) ensures 

continuity of care; (13) reimburses 

Clinical Centers of Excellence for 

infrastructure costs; (14) establishes a 

process for enrollment of WTC 

responders, and Pentagon and 

Shanksville responders; (15) conducts 

reviews to determine if cancer/types of 

cancer should be added to list of WTCrelated health conditions; (16) issues 

regulations for medical necessity; (17) 

reimburses costs for initial health 

evaluation, monitoring, and treatment; 

(18) establishes a process to determine 

and certify screening-eligible WTC 

survivors as certified-eligible survivors; 

(19) administers/collects recoupments 

from private insurance and workers 

compensation; (20) conducts and/or 

supports research; (21) ensures that a 

Registry of 9/11 victims is maintained; 

(22) enters into agreement(s) with the 

Centers for Medicare and Medicaid 

Services for provider reimbursements; 

and (23) ensures compliance with all 

Health Insurance Portability and 

Accountability Act of 1996 (HIPAA) 

Public Law 104–191, statutory and 

regulatory provisions that govern the 

WTCHP as a covered entity, as well as 

any HHS HIPAA policies through the 

establishment of a WTCHP HIPAA 

Compliance Program. 

Dated: April 28, 2014. 

Sherri A. Berger, 

MSPH, Chief Operating Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2014–10179 Filed 5–5–14; 8:45 am] 

BILLING CODE 4160–18–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–76, dated 

October 14, 1980, and corrected at 45 FR 

69296, October 20, 1980, as amended 

most recently at 79 FR 21760–21763, 

dated April 17, 2014) is amended to 

reflect the reorganization of the Human 

Capital and Resource Management 

Office, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

Section C–B, Organization and 

Functions, is hereby amended as 

follows: 

Delete in its entirety the title and the 

mission and function statements for the 

Human Capital and Resource 

Management Office (CAJQ) and insert 

the following: 

Human Resources Office (CAJQ). (1) 

Provides leadership, policy formation, 

oversight, guidance, service, and 

advisory support and assistance to the 

Centers for Disease Control and 

Prevention (CDC) and the Agency for 

Toxic Substances and Disease Registry 

(ATSDR); (2) collaborates as 

appropriate, with the CDC Office of the 

Director (OD), Centers/Institute/Offices 

(CIOs), domestic and international 

agencies and organizations; and 

provides a focus for short-and long-term 

planning within the Human Resource 

Office (HRO); (3) develops and 

administers human capital and human 

resource management policies; (4) 

serves as the business steward for all 

CDC developed human capital and 

human resources management systems 

and applications; (5) develops, 

maintains, and human resources 

management systems and applications; 

(5) develops, maintains, and supports 

information systems to conduct 


sroberts on DSK5SPTVN1PROD with NOTICES